Is that all you are taking for your RA?? There is a bounty of safe and I mean safe additional articles available such as tumeric (in capsule form) curcumin (in capsule form) green lipped mussel, pine bark extract, glucosamine and chondroitin sulfate etc. There are some great formulas out there that incorporate many if not all of these.
Glad you are doing the fish oil thing however, remember, in an uncontrolled inflammatory state you want to adjust the ratio of your omega threes to your omega 6's. You want to bring them more in balance so do read up on that. You may want to make sure that you are not taking a mix with 6's as well. I see that you mention fish oil so I imagine you are just doing the threes.
Another thing to consider is that galactose is often if not always missing in the sugar chains (glyproteins) of the tissues of the affected joints.
You can google for glyconutrients and RA might want to spell it out and see what you find.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11844062Abnormal IgG galactosylation in MRL-lpr/lpr mice: pathogenic role in the development of arthritis.
Kuroda Y, Nakata M, Hirose S, Shirai T, Iwamoto M, Izui S, Kojima N, Mizuochi T.
Laboratory of Biomedical Research, Department of Applied Biochemistry, Tokai University, Hiratsuka, Japan.
MRL-lpr/lpr (MRL/lpr) mice spontaneously develop arthritis by an increase in the incidence of agalactosylated oligosaccharides in serum IgG, similar to rheumatoid arthritis patients. However, whether this association has a pathogenic significance is still unknown.
In this study, we analyzed the oligosaccharide structure of serum IgG in various MRL mice with or without arthritis, to clarify the relationship between the oligosaccharide abnormality and the development of arthritis.
The level of agalactosylation in serum IgG was comparable in both arthritis-free MRL/lpr and MRL-+/+ (MRL/+) mice at 6 weeks of age. In contrast, the incidence of IgG lacking galactose markedly increased in MRL/lpr mice at 6 months of age (the age at which arthritis occurred), compared with that from age-matched MRL/+ mice without arthritis. However, the proportion of agalactosylated IgG increased similarly in anti-CD4 monoclonal antibody-treated MRL/lpr mice at 6 months of age, despite the absence of the development of arthritis, because of depletion of CD4+ T cells.
These results suggest that the abnormality in IgG galactosylation of MRL/lpr mice developed in an age-dependent manner, but it did so independently of CD4+ T cell-dependent B-cell activation and is not a consequence of the development of arthritis.
PMID: 11844062